• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声在脂肪肝疾病中的诊断价值。

Diagnostic Value of Ultrasound in Fatty Liver Disease.

机构信息

Division of Gastroenterology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.

Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.

出版信息

Ultraschall Med. 2021 Apr;42(2):128-153. doi: 10.1055/a-1352-4313. Epub 2021 Feb 23.

DOI:10.1055/a-1352-4313
PMID:33622003
Abstract

Hepatic steatosis is a commonly seen phenomenon in clinical practice and is the result of the accumulation of lipids in the hepatocytes. In most cases steatosis refers to nonalcoholic fatty liver disease (NAFLD), but it also occurs in other diseases of the liver parenchyma of a different etiology and is the result of the dysregulation of metabolic processes. Consequently, inflammatory processes can induce progressive fibrosis. Due to the high prevalence of fatty liver disease, a further increase in metabolic liver cirrhosis with corresponding complications can be expected in the near future. Due to its broad availability, ultrasound is particularly important, especially for the management of NAFLD. In addition to diagnosis and risk stratification, the monitoring of high-risk patients in NAFLD is becoming increasingly clinically important. Multimodality ultrasound includes B-mode and duplex methods, analysis of tissue stiffness (elastography), contrast-enhanced imaging (CEUS), and steatosis quantification. When using ultrasound in fatty liver disease, a standardized approach that takes into account the limitations of the method is essential.

摘要

肝脂肪变性是临床实践中常见的现象,是肝细胞内脂质积聚的结果。在大多数情况下,脂肪变性是指非酒精性脂肪性肝病(NAFLD),但也发生在其他不同病因的肝实质疾病中,是代谢过程失调的结果。因此,炎症过程可诱导进行性纤维化。由于脂肪肝的高患病率,预计在不久的将来,代谢性肝硬化及其相应并发症的发病率会进一步增加。由于超声检查的广泛应用,尤其是在 NAFLD 的管理中,超声检查尤为重要。除了诊断和风险分层外,NAFLD 高危患者的监测在临床上也变得越来越重要。多模态超声包括 B 型和双功能方法、组织硬度分析(弹性成像)、对比增强成像(CEUS)和脂肪变性定量。在使用超声检查脂肪肝时,必须采用一种考虑到方法局限性的标准化方法。

相似文献

1
Diagnostic Value of Ultrasound in Fatty Liver Disease.超声在脂肪肝疾病中的诊断价值。
Ultraschall Med. 2021 Apr;42(2):128-153. doi: 10.1055/a-1352-4313. Epub 2021 Feb 23.
2
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.床旁超声在非酒精性脂肪性肝病诊断中的应用
World J Gastroenterol. 2014 Jun 14;20(22):6821-5. doi: 10.3748/wjg.v20.i22.6821.
3
Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.胎球蛋白 B 与非酒精性脂肪性肝病肝纤维化标志物的相关性。
Endocrine. 2017 Nov;58(2):246-252. doi: 10.1007/s12020-017-1417-z. Epub 2017 Sep 15.
4
Imaging of nonalcoholic fatty liver disease and its clinical utility.非酒精性脂肪性肝病的影像学表现及其临床应用。
Hormones (Athens). 2018 Mar;17(1):69-81. doi: 10.1007/s42000-018-0012-x. Epub 2018 Apr 10.
5
MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.磁共振弹性成像可有效用于非酒精性脂肪性肝病患者肝纤维化和坏死性炎症活动的无创评估。
Eur J Radiol. 2018 Jan;98:82-89. doi: 10.1016/j.ejrad.2017.11.003. Epub 2017 Nov 11.
6
Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.评估脂肪变性和纤维化:声学结构定量与现有技术的比较。
World J Gastroenterol. 2015 Apr 28;21(16):4894-902. doi: 10.3748/wjg.v21.i16.4894.
7
How histopathologic changes in pediatric nonalcoholic fatty liver disease influence in vivo liver stiffness.儿科非酒精性脂肪性肝病的组织病理学变化如何影响活体肝硬度。
Acta Biomater. 2021 Mar 15;123:178-186. doi: 10.1016/j.actbio.2021.01.019. Epub 2021 Jan 17.
8
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
9
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝脏疾病的无创评估。
Gastroenterology. 2019 Apr;156(5):1264-1281.e4. doi: 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18.
10
Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.放射影像学在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的应用。
Clin Liver Dis. 2018 Feb;22(1):93-108. doi: 10.1016/j.cld.2017.08.005. Epub 2017 Oct 10.

引用本文的文献

1
HEPNET Position Statement-I, Case Definition, Classification, Screening & Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Pakistan: A Resource for Primary and Secondary Care Physicians.巴基斯坦肝脏网络立场声明 - I,代谢功能障碍相关脂肪性肝病(MASLD)的病例定义、分类、筛查与诊断:基层和二级医疗医生资源
Pak J Med Sci. 2025 Mar;41(3):929-938. doi: 10.12669/pjms.41.3.10081.
2
Pancreatic Enzyme Replacement Leads to Increased Vitamin D Uptake in Patients Undergoing Sleeve-gastrectomy - A Prospective, Monocentric Trial.行胃旁路术后患者应用胰酶替代治疗可增加维生素 D 的吸收:一项前瞻性单中心试验。
Obes Surg. 2024 Nov;34(11):4106-4115. doi: 10.1007/s11695-024-07526-5. Epub 2024 Oct 7.
3
An Optimized Strategy Based on Conventional Ultrasound for Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease.
一种基于传统超声的诊断代谢功能障碍相关脂肪性肝病的优化策略。
Diagnostics (Basel). 2023 Nov 22;13(23):3503. doi: 10.3390/diagnostics13233503.
4
The application of high-performance ultrasound probes increases anatomic depiction in obese patients.高性能超声探头的应用增加了肥胖患者的解剖描述。
Sci Rep. 2023 Sep 28;13(1):16297. doi: 10.1038/s41598-023-43509-9.
5
The feasibility and satisfaction study of 5G-based robotic teleultrasound diagnostic system in health check-ups.基于 5G 的远程机器人超声诊断系统在健康检查中的可行性和满意度研究。
Front Public Health. 2023 Jul 10;11:1149964. doi: 10.3389/fpubh.2023.1149964. eCollection 2023.
6
The German Gestational Diabetes Study (PREG), a prospective multicentre cohort study: rationale, methodology and design.德国妊娠糖尿病研究(PREG),一项前瞻性多中心队列研究:基本原理、方法和设计。
BMJ Open. 2022 Feb 15;12(2):e058268. doi: 10.1136/bmjopen-2021-058268.